Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. 1985

B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani

Cefotaxime diffused consistently and in therapeutic levels into the cerebrospinal fluid (CSF) of 13 children successfully treated for bacterial meningitis. CSF cefotaxime levels early (6.0 micrograms/ml) and late (1.2 micrograms/ml) in treatment were severalfold the MBCs for the infecting organisms. After a single 40-mg/kg dose to each of five infants with ventriculostomies, mean CSF levels of cefotaxime were 6.4, 5.7, and 4.5 micrograms/ml at 2, 4, and 6 h, respectively.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
January 1983, Antimicrobial agents and chemotherapy,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
December 1981, The Journal of pediatrics,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
June 1984, Pathologie-biologie,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
May 1985, Pathologie-biologie,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
December 1984, Presse medicale (Paris, France : 1983),
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
April 1992, The Journal of antimicrobial chemotherapy,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
January 1986, Infection,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
June 1985, The Japanese journal of antibiotics,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
November 2005, International journal of antimicrobial agents,
B I Asmar, and M C Thirumoorthi, and J A Buckley, and D M Kobos, and A S Dajani
January 1982, Reviews of infectious diseases,
Copied contents to your clipboard!